Whether you are researching this compound for the first time or comparing additive options before starting a protocol, you will find specific answers here, not vague summaries
2.2.3 Duration of disease, motor symptoms, non-motor symptoms, and associated microbiota The composition of gut microbiota might vary whether PD has an early or late onset
135 Zarean, E
doi: 10.3389/fmed.2026.1761721 Received 09 December 2025 Revised 12 January 2026 Accepted 26 January 2026 Published 20 February 2026 Volume 13 - 2026 Edited by Constantin Caruntu, Carol Davila University of Medicine and Pharmacy, Romania Reviewed by Mahmood Ahmed, University of Education Lahore, Pakistan Mohammad Amin Raeisi Estabragh, Kerman Medical University, Iran Updates Copyright 2026 Sanlier, Sacinti, Turkoglu and Sanlier
Tirzepatide, a single-molecule agonist of both GLP-1 and GIPR, demonstrated remarkable efficacy in the SURPASS and SURMOUNT clinical trial programs
Its given either by injection into a muscle or under the skin